OakChart

Pro-Dex Inc

PDEXHealthcare·Medical Instruments & Supplies·USA·Micro·NASD·Nov 11 • 9:50 AM ET

71.01+1.15 (1.65%)
2026-11-11 15:52 CET
Market cap
223.55 USD m
Revenue, TTM
79.58 USD m
Net income, TTM
12.03 USD m
Free cash flow, TTM
10.69 USD m
EPS diluted, TTM
3.65
P/E
19.44
Compare

Price

PDEX against its 20, 50 and 200-day averages
2050200earnings
40.0050.0060.0070.00117K235KMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26PDEXclose 71.0120-day 62.1650-day 64.86200-day 57.5071.01

7.8% under 77.00 on 4 Sep 2026. Last 15 sessions, 23.8% high to low

Profile

PDEX
52-week range, 88% of the way up
28.8177.00

Pro-Dex, Inc. engages in the design, manufacture, sale, and repair of handheld medical devices and accessories. Its products include finished medical devices, micro air-motors, powered surgical drivers, and precision air powered motors. The company was founded in March 1978 and is headquartered in Irvine, CA.

IndexRUT
Employees206
IPOAug 07, 1986
Beta0.08
ATR, 14d3.35
Rel volume0.18
Short float13.30%
Insider own36.36%
Inst own33.98%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap227.23M
Enterprise Value233.22M
Income12.03M
Sales79.58M
Book/sh15.40
Cash/sh4.06
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees206
IPOAug 07, 1986

Ratios

P/E19.44
Forward P/E21.13
PEG-
P/S2.86
P/B4.61
P/C17.49
P/FCF21.26
EV/EBITDA15.67
EV/Sales2.93
Quick Ratio2.49
Current Ratio4.18
Debt/Eq0.38
LT Debt/Eq0.29
Option/ShortNo / Yes

Earnings

EPS (ttm)3.65
EPS next Y3.36
EPS next Q0.72
EPS this Y-25.00%
EPS next Y8.74%
EPS next 5Y-
EPS past 3/5Y28.41% 22.74%
Sales past 3/5Y18.94% 15.32%
EPS Y/Y TTM9.26%
Sales Y/Y TTM13.31%
EPS Q/Q-34.42%
Sales Q/Q10.96%
EarningsOct 29 AMC
EPS/Sales Surpr.37.31% 0.78%

Ownership

Insider Own36.36%
Insider Trans-2.78%
Inst Own33.98%
Inst Trans-1.11%
ROA17.08%
ROE26.48%
ROIC18.88%
Gross Margin32.79%
Oper. Margin16.84%
Profit Margin15.12%
SMA2014.23%
SMA509.49%
SMA20023.49%
Trades-

Technical

Shs Outstand3.20M
Shs Float2.04M
Short Float13.30%
Short Ratio4.61
Short Interest0.27M
52W High77.00 -7.78%
52W Low28.81 146.48%
Volatility6.02% 5.14%
ATR (14)3.35
RSI (14)64.38
Beta0.08
Rel Volume0.18
Avg Volume58.80K
Volume1,070

Performance

Perf Week11.93%
Perf Month14.04%
Perf Quarter4.58%
Perf Half Y23.62%
Perf YTD84.54%
Perf Year111.28%
Perf 3Y291.89%
Perf 5Y187.11%
Perf 10Y1478.00%
Recom1.00
Target Price74.00
Prev Close69.86
Price71.01
Change %1.65%

Peers

Mkt cap
TickerCompanyMkt cap
POCIPrecision Optics Corp Inc54.86M
ITGRInteger Holdings Corp4.31B
CNMDConmed Corp1.53B
UFPTUFP Technologies Inc2.45B
UTMDUtah Medical Products Inc208.24M
KRMDKORU Medical Systems Inc165.75M
SYKStryker Corp121.68B
ZBHZimmer Biomet Holdings Inc20.28B
KIDSOrthoPediatrics corp892.20M
OFIXOrthofix Medical Inc300.60M

Insider trading

9 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Van Kirk Richard Lee JrChief Executive OfficerSep 11 '26Sale59.3676545,41279,228Sep 14 07:30 PM
Van Kirk Richard Lee JrChief Executive OfficerSep 09 '26Sale60.5819,2351,165,29079,993Sep 10 08:20 PM
Charlton AlishaChief Financial OfficerSep 09 '26Sale61.302,300140,98321,870Sep 10 08:19 PM
Van Kirk Richard Lee JrOfficerSep 09 '26Proposed Sale64.7020,0001,294,000Sep 09 10:36 AM
Alisha CharltonChief Financial OfficerSep 09 '26Proposed Sale73.412,300168,843Sep 08 06:00 PM
Domingo Angelita RebamontanDirectorMar 16 '26Sale47.2499847,14618,779Jul 14 06:00 PM
Van Kirk Richard Lee JrChief Executive OfficerMay 21 '26Sale62.815,872368,81093,835May 26 07:16 PM
Van Kirk Richard Lee JrChief Executive OfficerMay 22 '26Sale62.364,128257,43889,707May 26 07:16 PM
Van Kirk Richard Lee JrOfficerMay 21 '26Proposed Sale62.8410,000628,417May 21 10:18 AM

Held by

AUM
TickerCompanyAUM
IWMiShares Russell 2000 Index FundAUM: 77.38B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
DFASU.S. Small Cap Portfolio-ETF Class Shares-
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
DFACU.S. Core Equity 2 Portfolio-ETF Class Shares-
FDMFirst Trust Dow Jones Select Microcap Index FundAUM: 267.52M
IWCiShares Micro-Cap ETFAUM: 1.22B
DCORUS Core Equity 1 Portfolio ETF Class Shares-

News

latest 14 of 206
  • Pro-Dex, Inc. Announces Fiscal 2027 First Quarter Results (ACCESSWIRE) -5.58%
  • Dell Afterglow Continues. These Other Stocks Top Buy Points. (Investor's Business Daily) +18.88%
  • Pro-Dex, Inc. Announces Fiscal 2026 Fourth Quarter and Full-Year Results (ACCESSWIRE)
  • Pro-Dex, Inc. Announces Fiscal 2026 Third Quarter and Nine Month Results (ACCESSWIRE)
  • Pro-Dex, Inc. Announces Acquisition of Advanced Precision Machining (ACCESSWIRE)
  • Loading…
  • Pro-Dex, Inc. Announces Fiscal 2026 Second Quarter and Six-Month Results (ACCESSWIRE)
  • Pro-Dex, Inc. Announces Contract Extension With Largest Customer (ACCESSWIRE) -8.30% +10.34%
  • Long Cast Advisers' Updates on Pro-Dex (PDEX) (Insider Monkey)
  • Pro-Dex, Inc. (PDEX) Q1 Earnings and Revenues Top Estimates (Zacks) +18.32%
  • Pro-Dex, Inc. Announces Fiscal 2026 First Quarter Results (ACCESSWIRE)
  • West Pharmaceutical Services (WST) Tops Q3 Earnings and Revenue Estimates (Zacks) +6.49%
  • Pro-Dex, Inc. Announces Clarification Related to Trading Symbol (ACCESSWIRE) +9.68%
  • Pro-Dex, Inc. (PDEX) Lags Q4 Earnings and Revenue Estimates (Zacks) -16.51%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2027Q12026-10-290.9200.6700.92020.5620.401
2026Q42026-09-030.8700.6700.86720.4119.201
2026Q32026-04-301.200-1.20419.95--
2026Q22026-01-290.660-0.66218.66--
2026Q12025-10-301.400-1.40218.53--
2025Q42025-09-040.3600.4700.35717.4917.901
2025Q32025-05-010.9800.4700.98117.4117.701
2025Q22025-01-300.6100.3800.61116.7913.801
2025Q12024-10-310.7500.2900.74914.8912.001
2024Q42024-09-050.4600.3500.45715.0311.001
2024Q32024-05-020.1900.3500.18614.2913.201
2024Q22024-02-090.1400.3500.13812.5911.501
2024Q12023-11-02-0.170--0.17311.94--
2023Q42023-10-120.4200.3301.05410.6012.001
2023Q32023-05-04--0.36213.08--
2023Q22023-02-030.2400.2900.24111.2810.401

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2017FY1.1901.0901.19821.9421.00
2018FY0.560-0.37022.46-
2019FY0.9700.9700.96527.1727.17
2020FY1.5001.0501.49934.8330.85
2021FY1.1301.2001.47938.0339.00
2022FY1.0200.8301.21542.0438.40
2023FY1.950-1.94546.00-
2024FY0.6000.5000.59653.8449.00
2025FY2.6702.8102.67166.5967.00
2026FY4.1203.9404.12077.5576.40
2027FY-3.090--82.70
2028FY-3.360--86.80

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2027Q2S2026-10-3011020.5020.5020.50
2027Q2S2026-09-0911020.5020.5020.50
2027Q2S2026-05-0810019.8019.8019.80
2027Q2E2026-10-301100.720.720.72
2027Q2E2026-09-091100.720.720.72
2027Q2E2026-05-081000.690.690.69
2027Q1S2026-09-0911020.4020.4020.40
2027Q1S2026-05-0810019.6019.6019.60
2027Q1E2026-09-091100.670.670.67
2027Q1E2026-05-081000.660.660.66
2027FYS2026-09-0911082.7082.7082.70
2027FYS2026-05-0810081.0081.0081.00
2027FYE2026-09-091103.093.093.09
2027FYE2026-05-081002.782.782.78

Estimate history

EPS, annual0.370.9651.4991.4791.2151.9450.5962.6714.1193.6529
Period201820192020202120222023202420252026TTM
EPS, quarterly0.7490.6110.9810.3571.4020.6621.2040.8670.919
PeriodQ1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27
Sales, annual22.46527.17234.83438.02942.04146.08753.84466.59377.54879.58
Period201820192020202120222023202420252026TTM
Sales, quarterly14.89216.79317.41417.49418.5318.66319.94920.40520.56
PeriodQ1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27
Shares, annual4.3314.0393.8113.6463.5963.5453.3633.2613.1863.203
Period201820192020202120222023202420252026MRQ
Shares, quarterly3.2983.263.2613.2613.2623.213.1973.1863.203
PeriodQ1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Income statement, annual

Currency USD, millions
MetricTTM2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Total Revenue79.5877.5566.5953.8446.0942.0438.0334.8327.17
Cost of Goods Sold Incl. D&A53.4953.2747.0839.2933.2928.6824.4521.7117.39
Gross Profit26.0924.2719.5114.5512.8013.3613.5713.139.78
Selling, General and Administrative Excl. Other12.4311.288.827.386.997.979.056.074.79
Research and Development3.793.323.643.192.802.984.382.301.88
Other Operating Expense0.270.000.000.000.050.230.000.000.00
Operating Income13.4012.9910.697.175.765.164.537.064.99
Interest Expense0.870.810.830.560.530.460.350.240.22
Unusual Expense-0.070.00-1.524.12-3.90-0.93-1.37-0.950.00
Net Income Before Taxes15.1718.0212.062.639.435.697.007.905.45
Income Taxes3.144.353.080.512.351.121.181.791.30
Consolidated Net Income12.0313.668.982.137.074.575.826.114.15
Net Income From Continuing Operations12.0313.668.982.137.074.575.826.114.15
Net Income12.0313.668.982.137.074.575.826.114.15
EPS (Recurring)3.614.122.351.401.191.041.241.340.97
EPS (Basic, Before Extraordinaries)3.754.242.730.611.981.261.531.560.99
EPS (Diluted)3.654.122.670.601.951.211.481.500.96
EBITDA14.8814.3811.938.336.625.885.257.675.43
Non-Operating Income (Expense)2.575.840.680.140.300.071.450.120.68
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.520.540.440.480.611.010.660.210.03
Price To Earnings Ratio19.1219.1215.5916.309.8015.4827.0511.7316.26
Price To Sales Ratio2.872.502.201.301.511.433.162.092.05
Gross Margin32.7931.3029.3027.0227.7831.7935.7037.6935.99
Operating Margin16.8416.7516.0513.3212.5012.2711.9020.2718.37
Net Margin15.1217.6213.483.9515.3510.8815.3117.5515.27
Shares Outstanding3.203.193.263.363.553.603.653.814.04
Market Capitalization223.55223.55142.3167.1567.7257.72111.4967.9153.39

Income statement, quarterly

Currency USD, millions
Metric2027Q12026Q42026Q32026Q22026Q12025Q42025Q32025Q2
Total Revenue20.5620.4119.9518.6618.5317.4917.4116.79
Cost of Goods Sold Incl. D&A13.4413.3113.8212.9212.7814.0011.2911.72
Gross Profit7.127.096.135.745.753.496.125.07
Selling, General and Administrative Excl. Other3.343.563.042.482.262.152.162.38
Research and Development1.211.020.830.730.770.910.950.94
Other Operating Expense0.270.000.000.000.380.000.330.00
Operating Income3.523.533.093.263.111.343.642.69
Interest Expense0.260.270.200.140.200.230.250.20
Unusual Expense-0.070.000.000.00-3.30-0.46-0.55-0.08
Net Income Before Taxes3.383.525.342.936.221.604.552.59
Income Taxes0.330.671.400.741.540.401.280.55
Consolidated Net Income3.052.863.942.194.681.203.272.04
Net Income From Continuing Operations3.052.863.942.194.681.203.272.04
Net Income3.052.863.942.194.681.203.272.04
EPS (Recurring)0.900.871.200.660.710.260.870.60
EPS (Basic, Before Extraordinaries)0.950.901.230.671.430.371.000.63
EPS (Diluted)0.920.871.200.661.400.360.980.61
EBITDA3.923.943.463.573.421.663.953.00
Non-Operating Income (Expense)0.050.272.45-0.190.010.020.610.02
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.110.140.150.130.130.120.120.10
Price To Earnings Ratio19.1216.1514.4411.4812.5415.5924.7530.55
Price To Sales Ratio2.872.492.151.761.612.202.582.56
Gross Margin34.6534.7530.7430.7731.0119.9635.1730.20
Operating Margin17.1017.2915.5117.4616.787.6820.9016.03
Net Margin14.8214.0019.7411.7225.266.8418.8112.15
Shares Outstanding3.203.193.203.213.263.263.263.26
Market Capitalization223.55186.94157.48125.52110.42142.31161.68152.37

Balance sheet, annual

Currency USD, millions
Metric2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Cash & Short Term Investments9.347.166.854.071.605.028.9810.397.41
Short Term Receivables21.8217.4913.899.9515.3810.935.164.104.13
Inventories21.4622.2115.2716.1712.688.448.246.244.39
Other Current Assets0.550.410.340.300.790.430.140.620.27
Total Current Assets53.1847.2736.3530.4830.4624.8222.5221.3516.20
Net Property, Plant & Equipment11.9412.2612.6513.2013.4212.895.632.731.75
Total Investments and Advances0.500.151.567.524.081.702.360.580.00
Long-Term Note Receivable-------0.000.04
Intangible Assets7.210.030.050.080.120.190.160.130.14
Deferred Tax Assets2.503.443.293.012.391.830.880.872.15
Other Assets0.130.070.300.540.750.260.200.470.10
Total Assets75.4763.2154.2154.8351.2241.6931.7526.1320.39
Short Term Debt Incl. Current Port. of LT Debt5.056.654.834.243.661.580.990.620.04
Accounts Payable4.264.614.512.263.762.291.972.001.08
Income Tax Payable0.120.190.630.450.540.40--0.13
Other Current Liabilities3.553.182.922.723.382.002.271.651.29
Total Current Liabilities12.9814.6312.899.6811.356.275.234.272.54
Long Term Debt13.899.938.7210.5512.3013.976.033.930.01
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities0.962.021.733.022.131.360.620.610.48
Other Liabilities0.000.000.000.000.000.000.800.310.10
Total Liabilities27.8426.5823.3423.2425.7921.6012.699.133.12
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity47.6336.6330.8731.5925.4320.0819.0617.0117.28
Total Shareholders Equity47.6336.6330.8731.5925.4320.0819.0617.0117.28
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity47.6336.6330.8731.5925.4320.0819.0617.0117.28
Total Liabilities & Stockholders Equity75.4763.2154.2154.8351.2241.6931.7526.1320.39
Book Value Per Share14.9511.239.188.917.075.515.004.213.99
Tangible Book Value Per Share12.6911.239.168.897.045.464.964.183.96
Full-Time Employees2061811481461351181179780
Price to Book Ratio4.544.032.192.142.425.553.563.041.66
Return on Assets19.7015.293.9013.649.8415.8521.1217.838.64
Return on Equity32.4326.606.8125.6020.0929.7433.8924.2010.46
Return on Invested Capital22.2119.285.3716.7912.1217.0924.3619.819.38
Quick Ratio2.441.711.641.481.572.612.733.544.65
Current Ratio4.103.232.823.152.683.964.315.006.38

Cash flow, annual

Currency USD, millions
MetricTTM2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Net Income12.0313.668.982.137.074.575.826.114.15
Depreciation1.491.391.241.160.860.730.710.610.44
Other Funds (Non Cash)-1.50-4.64-1.584.72-3.130.46-1.74-0.68-0.33
Funds from Operations11.8910.298.776.455.075.694.616.025.67
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-0.47-3.05-10.45-0.230.40-6.54-6.69-1.08-2.35
Income Taxes Payable-1.630.37-1.500.18-0.090.15-0.410.640.04
Cash from Operating Activities11.427.24-1.686.225.46-0.85-2.084.953.33
Capital Expenditures-0.73-0.48-1.25-0.98-0.97-1.67-8.31-0.56-1.40
Net Assets From Acquisitions-6.49-6.490.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.010.01
Purchase or Sale of Investments10.8910.891.01-1.250.090.444.60-2.69-1.07
Purchase of Investments-0.35-0.35-0.90-1.250.00-0.330.00-2.82-2.98
Sale Or Maturity of Investments11.2411.241.910.000.090.774.600.131.91
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.971.24
Cash from Investing Activities3.673.91-0.24-2.23-0.89-1.24-3.71-2.29-1.22
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-3.91-3.32-3.46-3.46-1.46-1.55-5.44-3.35-3.96
Repurchase of Common Pref Stock-4.01-3.41-3.50-3.50-1.55-1.61-5.54-3.39-3.98
Sale of Common Pref Stock0.100.090.040.050.090.060.100.040.03
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net1.02-0.033.48-0.84-0.810.768.79-0.634.51
Change in Long Term Debt1.02-0.033.48-0.84-0.810.768.79-0.634.51
Issuance of Long Term Debt14.1823.6215.004.005.282.009.140.004.94
Reduction of Long Term Debt-13.16-23.65-11.53-4.84-6.09-1.24-0.35-0.63-0.43
Net Financing Active Other Cash Flow-0.95-0.03-0.300.00-0.220.00-0.260.00-0.10
Other Financing Activities Uses-0.95-0.03-0.300.00-0.220.00-0.260.00-0.10
Cash from Financing Activities-3.84-3.38-0.29-4.30-2.49-0.793.09-3.980.45
Net Change in Cash11.247.77-2.21-0.302.09-2.87-2.70-1.322.55
Free Cash Flow10.696.76-2.935.244.49-2.48-10.354.431.94
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow21.4028.73-13.3815.48--16.4228.77
Deferred Taxes & Investment Tax Credit--0.130.14-1.560.26-0.06-0.18-0.021.42

Balance sheet, quarterly

Currency USD, millions
Metric2027Q12026Q42026Q32026Q22026Q12025Q4
Cash & Short Term Investments12.999.3410.988.8210.557.16
Short Term Receivables18.5921.8219.7718.1518.3417.49
Inventories21.9021.4622.3621.7121.5622.21
Other Current Assets0.440.550.560.340.230.41
Total Current Assets53.9253.1853.6749.0150.6947.27
Net Property, Plant & Equipment13.3511.9412.2411.6011.9512.26
Total Investments and Advances0.500.500.460.140.150.15
Intangible Assets7.197.217.240.010.020.03
Deferred Tax Assets1.542.501.281.281.423.44
Other Assets0.090.130.100.220.080.07
Total Assets76.5975.4774.9862.2664.3063.21
Short Term Debt Incl. Current Port. of LT Debt4.625.055.032.995.126.65
Accounts Payable5.324.265.254.113.964.61
Income Tax Payable0.120.120.741.200.780.19
Other Current Liabilities2.813.553.623.903.743.18
Total Current Liabilities12.8812.9814.6412.2013.6014.63
Long Term Debt14.3613.8915.148.429.189.93
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities-0.96---2.02
Other Liabilities0.000.000.000.000.000.00
Total Liabilities27.2427.8429.7820.6222.7926.58
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity49.3547.6345.2041.6341.5136.63
Total Shareholders Equity49.3547.6345.2041.6341.5136.63
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity49.3547.6345.2041.6341.5136.63
Total Liabilities & Stockholders Equity76.5975.4774.9862.2664.3063.21
Book Value Per Share15.4014.9514.1412.9712.7311.23
Tangible Book Value Per Share13.1612.6911.8812.9712.7211.23
Full-Time Employees-206---181
Price to Book Ratio4.544.143.793.023.014.03
Return on Assets17.0819.7017.2418.4918.8715.29
Return on Equity26.4832.4329.8330.8730.9226.60
Return on Invested Capital4.784.646.534.379.232.57
Quick Ratio2.492.442.142.242.141.71
Current Ratio4.184.103.674.023.733.23

Cash flow, quarterly

Currency USD, millions
Metric2027Q12026Q42026Q32026Q22026Q12025Q4
Net Income3.052.863.942.194.681.20
Depreciation0.400.410.360.310.310.31
Other Funds (Non Cash)-0.000.33-2.250.42-3.14-0.32
Funds from Operations3.453.332.063.061.851.33
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital3.04-3.60-0.420.510.46-1.50
Income Taxes Payable-0.46-0.93-0.500.261.54-1.25
Cash from Operating Activities6.49-0.271.633.572.31-0.17
Capital Expenditures-0.35-0.20-0.11-0.07-0.10-0.09
Net Assets From Acquisitions0.000.00-6.500.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.401.558.940.00-0.90
Purchase of Investments0.000.00-0.350.000.00-0.90
Sale Or Maturity of Investments0.000.401.908.940.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.350.20-5.058.87-0.10-0.99
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-0.54-0.60-0.56-2.210.040.00
Repurchase of Common Pref Stock-0.60-0.60-0.60-2.210.000.00
Sale of Common Pref Stock0.060.000.040.000.040.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-1.11-1.136.02-2.77-2.16-2.89
Change in Long Term Debt-1.11-1.136.02-2.77-2.16-2.89
Issuance of Long Term Debt0.001.577.155.469.442.11
Reduction of Long Term Debt-1.11-2.69-1.13-8.23-11.60-5.00
Net Financing Active Other Cash Flow-0.930.000.00-0.030.000.00
Other Financing Activities Uses-0.930.000.00-0.030.000.00
Cash from Financing Activities-2.58-1.735.46-5.00-2.12-2.89
Net Change in Cash3.57-1.802.047.440.10-4.05
Free Cash Flow6.14-0.481.523.502.21-0.27
Price to Free Cash Flow21.4028.5423.0521.11--

Revenue breakdown

Surgical & Medical Instruments & Apparatus2025: 66.59M 2026: 77.55M
United States2025: 66.59M 2026: 77.55M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3013.30%0.3M2.0M64.27K
2026-10-1511.45%0.2M2.1M75.45K
2026-09-309.82%0.2M2.0M83.62K
2026-09-1510.34%0.2M2.0M86.66K
2026-08-318.90%0.2M2.0M81.90K
2026-08-149.71%0.2M2.0M81.35K
2026-07-318.54%0.2M2.0M70.94K
2026-07-157.85%0.2M2.0M57.00K
2026-06-307.36%0.1M2.0M44.54K
2026-06-158.22%0.2M2.0M34.89K
2026-05-297.13%0.1M2.0M29.12K
2026-05-159.50%0.2M2.0M25.95K
2026-04-3011.75%0.2M2.0M25.57K
2026-04-1511.24%0.2M2.0M25.62K
2026-03-3111.75%0.2M2.0M26.42K
2026-03-1310.83%0.2M2.0M28.30K
2026-02-2711.45%0.2M2.0M27.11K
2026-02-1311.22%0.2M2.0M29.25K
2026-01-3012.06%0.2M2.0M32.75K
2026-01-1510.77%0.2M2.1M40.68K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-308-KCurrent report2026-10-26SEC
2026-10-298-KCurrent report2026-10-29SEC
2026-10-2910-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-06ARSAnnual report to security holders. 2026-06-30SEC
2026-10-06DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-10-06DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-11-19SEC
2026-09-188-KCurrent report2026-09-16SEC
2026-09-144Statement of changes in beneficial ownership of securities2026-09-11SEC
2026-09-104Statement of changes in beneficial ownership of securities2026-09-09SEC
2026-09-104Statement of changes in beneficial ownership of securities2026-09-09SEC
2026-09-09144Filing for proposed sale of securities under Rule 144.SEC
2026-09-08144Filing for proposed sale of securities under Rule 144.SEC
2026-09-038-KCurrent report2026-09-03SEC
2026-09-0310-KAnnual report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-288-KCurrent report2026-08-26SEC
2026-07-244Statement of changes in beneficial ownership of securities2026-07-23SEC
2026-07-144Statement of changes in beneficial ownership of securities2026-03-16SEC
2026-07-064Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-07-064Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-07-064Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-06-26SCHEDULE 13D/ASEC
2026-06-178-KCurrent report2026-06-17SEC
2026-06-01SDSpecialized Disclosure ReportSEC
2026-05-264Statement of changes in beneficial ownership of securities2026-05-21SEC
2026-05-21144Filing for proposed sale of securities under Rule 144.SEC
2026-04-308-KCurrent report2026-04-30SEC
2026-04-3010-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-03-278-KCurrent report2026-03-23SEC
2026-02-128-KCurrent report2026-02-09SEC
2026-01-298-KCurrent report2026-01-29SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-09001.35M3
2026-080000
2026-070000
2026-060000
2026-0500626.25K2
2026-040000
2026-030047.15K1
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
BlackRock, Inc.4.80%
VANGUARD CAPITAL MANAGEMENT LLC2.58%
Global Retirement Partners, LLC2.46%
DIMENSIONAL FUND ADVISORS LP1.96%
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.1.65%
GEODE CAPITAL MANAGEMENT, LLC1.53%
JPMORGAN CHASE & CO1.01%
STATE STREET CORP0.98%
Pekin Hardy Strauss, Inc.0.71%
GOLDMAN SACHS GROUP INC0.59%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND1.90%
iShares Russell 2000 ETF1.68%
Fidelity Small Cap Index Fund0.71%
U.S. SMALL CAP PORTFOLIO0.69%
iShares Russell 2000 Growth ETF0.64%
VANGUARD EXTENDED MARKET INDEX FUND0.62%
VANGUARD RUSSELL 2000 INDEX FUND0.37%
Fidelity Extended Market Index Fund0.29%
College Retirement Equities Fund - Total Global Stock Account0.26%
Dimensional U.S. Small Cap ETF0.24%

OakChart. PDEX. Cached 15 minutes.

Some panels did not load: ratings.